The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...
Over the first half of 2026, Gelteq has commenced veterinary and pharmaceutical development programs, expanded its delivery platform, and advanced toward future clinical milestones including: "Our ...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it ...
GAINESVILLE, Fla.--(BUSINESS WIRE)--The University of Florida (UF) College of Pharmacy’s online graduate program in pharmaceutical outcomes and policy today announced the launch of a new track, ...
As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...
About This Series: This story is part of an ongoing Purdue Today series highlighting programs ranked in the Top 10 or Top 10th percentile among our peers nationally, demonstrating the university’s ...
MELBOURNE, Australia, June 17, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) ("Gelteq" or the "Company"), a biotechnology company developing a proprietary gel-based delivery platform for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results